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ExpressionSTAM2 (signal transducing adaptor molecule 2), a subunit of the ESCRT-0 complex, is an endosomal protein
acting as a regulator of receptor signaling and trafﬁcking. To analyze STAM2 in the nervous system, its gene
expression and protein localization in the mouse brain were identiﬁed using three methods: mRNA in situ
hybridization, immunohistochemistry, and via lacZ reporter in frame with Stam2 gene using the gene trap
mouse line Stam2Gt1Gaj. STAM2 intracellular localization was analyzed by subcellular fractionation and co-
immunoﬂuorescence using confocal microscopy. Stam2 was strongly expressed in the cerebral and cerebellar
cortex, hippocampal formation, olfactory bulb, and medial habenula. The majority of STAM2-positive cells co-
stainedwith the neuronalmarkers. In neurons STAM2was found in the early endosomes and also in the nucleus.
The other members of the ESCRT-0 complex co-localized with STAM2 in the cytoplasm, but they were not pres-
ent in the nucleus. The newly identiﬁed neuron-speciﬁc nuclear localization of STAM2, togetherwith its high ex-
pression in the brain indicated that STAM2 might have a speciﬁc function in the mouse nervous system.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
STAM2 (signal transducing adaptormolecule 2) is a 523 amino acid-
long protein encoded by Stam2 gene that belongs to the STAM protein
family. STAM2 has a characteristic domain organization consisting of a
VHS domain (Vps-27/Hrs/Stam) at its N-terminus, as well as a UIM
(ubiquitin-interacting motif), SH3 (Src homology 3), CC (“coiled coil”),
SSM (STAM-speciﬁc motif) and C-terminal ITAM (immunoreceptor
tyrosine-based activation motif) domain (Endo et al., 2000; Kato et al.,
2000; Lohi and Lehto, 2001; Mizuno et al., 2003, 2004).
STAM2 is suggested to play a regulatory role in the endosomal
sorting of ubiquitinated membrane proteins. Together with STAM1
and HRS (hepatocyte growth factor-regulated tyrosine kinase sub-
strate) it forms the endosome-associated complex ESCRT-0 (endosomalcule; VHS domain, Vps-27/Hrs/
c homology 3; CC, coiled coil;
e-based activation motif; HRS,
rate; ESCRT, endosomal sorting
cule with the SH3 domain of
dosome antigen 1.
l of Medicine, Croatian Institute
.
. This is an open access article undersorting process required for transport-0) implicated in the sorting of
mono-ubiquitinated endosomal cargo. Cargo destined toward the lyso-
somes for degradation is subjected to the ESCRTmachinery, which con-
sists of four protein complexes. A ubiquitinated tag is initially
recognized by the ESCRT-0 complex, followed by ESCRT-I, ESCRT-II
and ESCRT-III (Hurley, 2010; Roxrud et al., 2010; Williams and Urbé,
2007). A ubiquitin tag can be removed by speciﬁc deubiquitinating
enzymes: AMSH (associated molecule with the SH3 domain of STAM)
and UBPY (ubiquitin-speciﬁc protease Y). Both of them bind the SH3
domain of STAM (Kato et al., 2000) and this interaction is involved in
endosomal cargo sorting.
ESCRT dysfunction, aberrant endosomal trafﬁcking, and non-proper
ubiquitination and deubiquitination are related tomany neurodegener-
ative diseases (Lee and Gao, 2012; Rusten and Simonsen, 2008; Saksena
and Emr, 2009; Stuffers et al., 2009). There is increasing evidence that
endosomal dysfunction of the most upstream component of the ESCRT
system is involved in neuronal cell degeneration (Lee and Gao, 2012).
STAM1 and HRS conditional knock-out mice were shown to display a
loss of neurons in the CA3 region of the hippocampus (Tamai et al.,
2008; Yamada et al., 2001). Knockdown of AMSH or UBPY also impaired
deubiquitination in neurons; deletion of AMSH led to neuronal loss in
the CA1 subﬁeld of the hippocampus, while the loss of UBPY resulted
in embryonic lethality (Ishii et al., 2001; Niendorf et al., 2007). STAM2
knockout mice show no abnormalities at birth, but double knockout ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Stam2 expression in the adult mouse brain detected bymRNA in situ hybridization and β-galactosidase activity. (A a–k) Serial coronal brain cryosections analyzed by mRNA in situ
hybridization and lacZ staining detected by X-gal. The hemisphere on the left represents in situ hybridization autoradiographs of 20 μm-thin coronal sections of wild type (Stam2+/+)
mouse brain, whereas the hemisphere on the right represents β-galactosidase activity staining performed on 50 μm-thin coronal cryosections of Stam2Gt1Gaj/Gt1Gaj mouse brain.
(k) Speciﬁcity of X-gal stainingwas conﬁrmed by the absence of the signal in thewild type (Stam2+/+) brain sections incubatedwith X-gal, while speciﬁcity ofmRNA in situ hybridization
detection was conﬁrmed by the absence of the hybridization signal in the tissue sections incubated with the Stam2 sense probe. (l, m) Representative sagittal section provides an overall
view of the distribution of Stam2 mRNA in wild type (m) and Stam2Gt1Gaj (l) mouse brains detected by in situ hybridization (m) and X-gal staining (l). Bar = 1 mm. (B) Confocal
photomicrographs showing the co-localization of STAM2 and β-galactosidase in the pyramidal cells of the CA3 region of the hippocampus. Overlap in the distribution of STAM2 and β-
galactosidase proteins (arrows) conﬁrmed that lacZ insertion in the Stam2 gene reﬂected Stam2 expression. Bar = 10 μm. AnOB — anterior olfactory bulb, BlAN — basolateral nucleus
of amygdala, BmAN — basomedial nucleus of amygdala, CA1 — CA1 pyramidal layer of hippocampus, CA2 — CA2 pyramidal layer of hippocampus, CA3 — CA3 pyramidal layer of
hippocampus, CM— corpusmamillare, CP— caudoputamen, CTX— neocortex, DG— dentate gyrus, Sub— subiculum, DmHN— dorsomedial hypothalamic nucleus, GF— gyrus fasciolaris,
GLC— granular layer of cerebellum, GlL— glomerular layer of the main olfactory bulb, GrL— granular layer of the main olfactory bulb, LaAN— lateral nucleus of amygdala, LSN— lateral
septal nucleus, MCL—mitral cells layer of themain olfactory bulb, MH—medial habenula, NAcc— nucleus accumbens, PAN— posterior nucleus of amygdala, PCL— Purkinje cell layer of
cerebellum, PGM — pontine gray matter, and VmHN— ventromedial hypothalamic nucleus.
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Fig. 2. Representative higher magniﬁcation images of coronal brain sections showing Stam2mRNA expression in selected brain regions. Sections are counterstained with cresyl violet.
(A) Glomerular layer of the olfactory bulb, (B) granular layer of the olfactory bulb, (C) dentate gyrus (DG), (D) CA2–CA3 transition region of hippocampus, (E) caudoputamen (Cp),
and (F) cerebellum; GLC — granular cell layer. Bar = 1 mm.
106 K. Kapuralin et al. / Molecular and Cellular Neuroscience 67 (2015) 104–115STAM1 and STAM2 is embryonically lethal due to a defect in ventral
folding morphogenesis, implying that STAMs are indispensable for
embryo development and survival (Yamada et al., 2002).
Our recent study demonstrated strong Stam2 expression in the
developing nervous system, particularly in differentiating layers of theFig. 3. STAM2 andNeuN immunostaining in the different brain regions of 4-month-old (A) and
are 100 μm.telencephalic cortex and hippocampal formation (Ćurlin et al., 2012).
These ﬁndings, together with the strong Stam2 expression observed in
the enteric nervous system and the brain regions related to olfaction
(Čunko et al., 2008; Kapuralin et al., 2012), indicated a need to clarify
Stam2 expression in the central nervous system.12-month-old (B)mice; (a) cortex, (b) dentate gyrus, (c) cerebellum, (d) striatum. All bars
107K. Kapuralin et al. / Molecular and Cellular Neuroscience 67 (2015) 104–115In the present studywe described the precise anatomical distribution
and subcellular localization of STAM2 in the adult mouse brain using ra-
dioactive mRNA in situ hybridization and immunohistochemistry, and
indirectly via lacZ reporter gene activity in the gene trap mouse line
Stam2Gt1Gaj. Together with endosomal STAM2 localization, we revealed
a nuclear localization of STAM2 in neurons.2. Material and methods
2.1. Animals
Experiments were performed on 4 to 6 month (considered as adult)
and 12 month old (considered as old) male mice of wild type inbred
strain C57Bl/6NCrl and the gene trap line Stam2Gt1Gaj, kept on the
same background. Genotyping of transgenic animals was performed
with PCR using tail genomic DNA. The experiments were approved byTable 1
Relative levels of expression of Stam2 in the adult mouse brain observed using in situ
hybridization, lacZ staining and immunohistochemistry.
“–” no signal, “+” low signal, “++”moderate signal, “+++” high signal of Stam2. ISH: in
situhybridizationwith Stam2 probe, lacZ: lacZ reporter staining using X-gal, IHC: immuno-
histochemistry with STAM2 antibody.
Brain region ISH lacZ IHC
Telencephalon
Neocortex
Layer I – – –
Layer II +++ +++ +++
Layer III +++ +++ +++
Layer IV + + +
Layer V ++ ++ ++
Layer VI ++ ++ ++
Hippocampal formation
Pyramidal layer CA1 +++ +++ +++
Pyramidal layer CA2 +++ +++ +++
Pyramidal layer CA3 ++ ++ ++
Dentate gyrus +++ ++ +++
Subiculum ++ ++ ++
Gyrus fasciolaris +++ +++ +++
Amygdala
Lateral nucleus of amygdala ++ ++ ++
Basolateral nucleus of amygdala ++ ++ ++
Basomedial nucleus of amygdala ++ ++ ++
Posterior nucleus of amygdala ++ ++ ++
Olfactory areas
Main olfactory bulb, granular layer ++ ++ ++
Main olfactory bulb, glomerular layer +++ +++ +++
Main olfactory bulb, stratum plexiformes internum + + +
Main olfactory bulb, stratum plexiformes externum – – –
Main olfactory bulb, mitral cells layer + + +
Anterior olfactory bulb +++ +++ +++
Auxiliary olfactory bulb + + +
Piriform area +++ +++ +++
Striatum
Caudoputamen ++ ++ ++
Lateral septal nucleus + + +
Nucleus accumbens + + +
Diencehalon
Epithalamus
Medial habenula +++ +++ +++
Hypothalamus
Ventromedial hypothalamic nucleus +++ ++ +++
Dorsomedial hypothalamic nucleus +++ ++ +++
Zona incerta + + +
Corpus mamillare ++ + ++
Metencephalon
Cerebellum
Molecular layer – – –
Purkinje cell layer + + +
Granular layer +++ +++ +++
Pons
Pontine gray matter + + +
Pontine nuclei + + +the institutional Ethical Committee, and they were in line with the EU
directive 2010/63/EU. Every effort was taken to minimize the number
and suffering of animals.
The transgenic mouse line Stam2Gt1Gajwas generated by a gene trap
method (Skarnes et al., 1992; Thomas et al., 2000). A targeting vector
pKC199βgeo, containing a mouse Hoxc9 splice acceptor sequence and
fused promoterless genes lacZ and neoR, was integrated randomly into
embryonic stem cells. The resulting insertion in Stam2 gene was in the
intron between exons 2 and 3 (Ćurlin et al., 2006, 2012).
2.2. Primary neuronal cell culture
The primary neuronal cell culture was obtained from the wild-type
C57Bl/6NCrl newborn mice (P0), sacriﬁced by decapitation. The cortex
was dissected andminced with scissors in Hank's balanced salt solution
(HBSS; Gibco). Dissociation of neuronal tissue and single-cell suspen-
sion was obtained using accutase (Gibco) for 15 min at 37 °C. The
suspension was centrifuged, supernatant discarded and cells
resuspended in DMEM/F-12 + GlutaMAX medium supplemented
with N2, B27 and penicillin/streptomycin (all from Gibco). Cells were
plated on poly-D-lysine (0.1 mg/ml, 18 h at 37 °C; Sigma) and laminin
(10 μg/ml, 4 h at 37 °C; Sigma) coated 6-well plates (for subcellular
fractionation) or on coated coverslips in 24-well plates (for immunocy-
tochemistry) and maintained in the medium at 37 °C in humidiﬁed
atmosphere of 5% CO2 for 6 and 14 days. The plating density was
0.4 × 106 cells/ml.
2.3. Detection of β-galactosidase activity
Transcardial perfusion with PBS (phosphate-buffered saline) and
ﬁxative containing 2% formalin and 0.2% glutaraldehyde (Sigma-
Aldrich) in 0.01 M PBS (pH 7.4) was performed on adult transgenic
animals anesthetized intraperitoneally with Avertin (500 mg/kg).
Brains were dissected and postﬁxed by immersion in the same ﬁxative
for 1 h on ice. After rinsing in PBS, brains were frozen to −80 °C
in prefreezed isopentane (Sigma-Aldrich) and cut with a cryostat
(Leica CM1850) into 50–60 μm thick sections mounted subsequently
on SuperFrost microscope slides (Menzel-Glaser) and air-dried for 1–
3 h. After rinsing in PBS, sections were incubated in the X-gal
staining solution (0.5 mg/mL X-gal (5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside), 10 mM potassium ferricyanide, 10 mM potassium
ferrocyanide, 2 mMmagnesium chloride, 0.01% sodium deoxycholate,
and 0.01% Igepal; all from Sigma-Aldrich in 0.01 M PBS (pH 7.4))
under light protection at 37 °C overnight. The stained sections were
rinsed in PBS, dehydrated in ascending concentrations of ethanol,
cleared in Histo-Clear (National Diagnostics) and coverslipped with
Histomount (National Diagnostics). β-Galactosidase activity was visual-
ized under themicroscope (Olympus AX70) and documented by digital
photography (Canon EOS 400D) or using a computer scanner (Epson
Effection 4870 Photo).
2.4. mRNA in situ hybridization
mRNA in situ hybridization was performed according to a modiﬁed
method described previously (Wittmann et al., 2009). In brief, synthetic
DNA oligonucleotides complementary to the mRNA sequence of mouse
Stam2 (5′-CCT CTG TGA TTT TCT CCT TGC CAC CAG TTG GCG TCA CTG
TCA TCC-3′; Microsynth) were labeled with [35S]-dATP (PerkinElmer)
using terminal deoxynucleotidyltransferase (Roche).
C57Bl/6NCrl wild type mice were sacriﬁced by cervical dislocation
and the brains were quickly dissected and immediately frozen in
isopentane (Sigma-Aldrich). 20 μm-thick coronal and sagittal sections
were cut and thaw-mounted on poly-L-lysine coated slides and stored
at−20 °C until use. Frozen sections were rapidly immersed into ice-
cold 2% paraformaldehyde for 10 min, shortly rinsed in PBS, transferred
to 0.25% acetic anhydride in 0.1 M triethylamine hydrochloride for
Fig. 4. STAM2 localization in neurons and glial cells of the central nervous system. (A) STAM2 immunoreactivity was highly localized in neurons (arrows), which was demonstrated with
the neuronalmarker NeuN. STAM2was found in the cytoplasm and the nucleoplasm. (B, C) STAM2 localization in the cytoplasmof astrocytes (B) andmicroglia (C) (arrows) visualized by
GFAP and IBA1 antibody. (D)A very faint STAM2 signal (arrows)was found inO4-positive cells, indicating the absence of high Stam2 expression in the oligodendrocytes. All bars are 10 μm.
108 K. Kapuralin et al. / Molecular and Cellular Neuroscience 67 (2015) 104–11510 min at room temperature, dehydrated by ethanol series, and
delipidated with chloroform. Hybridization was performed for 18 h at
53 °C with a labeled oligonucleotide probe (0.8–106 cpm) in 50 μl
hybridization buffer (1× SSC (saline sodium citrate buffer), 0.05 M
sodium-phosphate buffer, 1× Denhard solution, 0.25 mg/ml tRNA,Fig. 5. STAM2 andNeuN double-labeling reveals co-localization of STAM2 andNeuN in different
(e) cerebellum. All bars are 10 μm. (B) Quantitative analysis of STAM2 and NeuN immunoreact
STAM2-positive cells were neurons.0.5 mg/ml salmon sperm DNA, 1 mM EDTA, and 0.01% SDS; all from
Sigma-Aldrich). The next day the sections were rinsed in 0.5× SSC buff-
er with 0.5 mM DTT (dithiothreitol) at 60 °C. They were further dipped
in 70% ethanol, dried, and exposed to Kodak BioMax MR Film for 2–
3 weeks at room temperature. Slides with the sections werebrain regions (arrows). (A) (a) (hippocampus), (b) cortex, (c) olfactory bulb, (d) striatum,
ivity in the region of the cortex, hippocampus and striatum conﬁrmed that the majority of
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110 K. Kapuralin et al. / Molecular and Cellular Neuroscience 67 (2015) 104–115subsequently autoradiographed using autoradiography emulsion, type
NTB (Kodak) for 3–6 weeks at 4 °C. The X-ray ﬁlms and dipped sections
were developed with D-19 developer (Kodak). Films were further
analyzed by computer scanning (Epson Effection 4870 Photo). Slides
with the sections were counterstained lightly with cresyl violet
(Sigma-Aldrich), dehydrated, cleared in Histo-Clear, and coverslipped
with Histomount. Autoradiographs were visualized under the micro-
scope (Olympus AX70) and digitalized with Canon EOS 400D.
Hybridization with the respective sense Stam2 oligonucleotides (5′-
GGA TGA CAG TGA CGC CAA CTG GTG GCA AGG AGA AAA TCA CAG
AGG-3′; Mycrosinth) was included as a control.
2.5. Immunohistochemistry and immunocytochemistry
Wild type mice were anesthetized using Avertin (500 mg/kg) and
then perfused transcardially with PBS and 4% paraformaldehyde
(pH 7.4). Brains were isolated and further ﬁxed by immersion in the
same ﬁxative at 4 °C overnight. They were washed in PBS and trans-
ferred to 10% sucrose followed by 30% sucrose in PBS at 4 °C. Coronal
and sagittal 20 μm-thick sections were cut with a cryostat and thaw-
mounted on Superfrost Plus (Menzel Glaser) coated slides.
For immunocytochemical analysis, neuronal cells isolated from the
cerebral cortex were ﬁxed in 4% paraformaldehyde (pH 7.4) for
15min at 4 °C. After rinsing in PBS, cellswere ready for immunolabeling.
Tissue sections and cells were immunolabeled with the primary
antibodies against STAM2 (rabbit polyclonal, diluted 1:200, Abcam,
ab63372; rabbit polyclonal, diluted 1:200, Bioworld Technology,
BS1807; and rabbit polyclonal, diluted 1:200, Santa Cruz Biotechnology,
sc-98681), AMSH (mousemonoclonal, diluted 1:50, Santa Cruz Biotech-
nology, sc-271641), EEA1 (mouse monoclonal, diluted 1:500, BD
Transduction Laboratories, 610457), GFAP (chicken polyclonal, diluted
1:300, Abcam, ab4674), HRS (mouse monoclonal, diluted 1:200, Santa
Cruz Biotechnology, sc166843), IBA1 (goat polyclonal, diluted 1:500,
Abcam, ab5076), MAP2 (chicken polyclonal, diluted 1:1200, Abcam,
ab5392), NeuN (mouse monoclonal, diluted 1:100, Millipore,
MAB377), O4 (mouse monoclonal, diluted 1:200, Millipore, MAB345),
STAM1 (goat polyclonal, diluted 1:100, Santa Cruz Biotechnology, sc-
6919), UBPY (mousemonoclonal, diluted 1:50, Santa Cruz Biotechnolo-
gy, sc-365481) and β-galactosidase (chicken polyclonal, diluted 1:250,
Abcam, ab9361). Primary antibodies were diluted in PBS containing
0.2% Triton-X-100 (Sigma-Aldrich) and 2% serum from the species in
which the secondary antibodywas raised at 4 °C overnight. After rinsing
in PBS, sections were further immunolabeled with the ﬂuorescent
secondary antibodies: Alexa Fluor 488 goat anti-rabbit (Invitrogen,
A11008), Alexa Fluor 488 donkey anti-rabbit (Invitrogen, A21206),
Alexa Fluor 488 rabbit anti-mouse (Invitrogen, A11059), Alexa Fluor
546 rabbit anti-chicken (Invitrogen, A11040), Alexa Fluor 546 rabbit
anti-mouse (Invitrogen, A11003), Alexa Fluor 546 donkey anti-goat
(Invitrogen, A11056) and Alexa Fluor 546 rabbit anti-goat (Invitrogen,
A21085). All secondary antibodies were diluted in PBS at a concentra-
tion of 1:500 (for the brain tissue) or 1:1000 (for the cell culture).
Incubation with the secondary antibody was performed for 2.5 h at
room temperature. DAPI (Roche) was used as a nuclear counterstain.
Finally, the sections and the cells were rinsed in PBS and coverslipped
using Fluoromount (Sigma-Aldrich). Fluorescent mono and double-
immunolabeling was analyzed by confocal microscope (Zeiss LSM 510
Meta).
2.6. Subcellular fractionation
Subcellular fractions were prepared from a primary neuronal
cell culture obtained from the cortex of wild type C57Bl/6NCrl
newborn mice with an NE-PER nuclear and cytoplasmic extraction kit
(Thermo Scientiﬁc) as per the manufacturer's instructions. All lysis
buffers were supplemented with Halt™ Protease Inhibitor Cocktail
(Thermo Scientiﬁc).Brieﬂy, accutase (Gibco) was added to the wells of the 6-well plate
where the neurons were cultured. After 10 min, cells were washed
with PBS and transferred to a 1.5 ml microcentrifuge tube and pelleted
by centrifugation at 500 g for 3 min. Ice cold cytoplasmic extraction
reagent I was then added to the cell pellet, and the tube was vortexed
and incubated on ice for 15min. Further, ice cold cytoplasmic extraction
reagent II was added and the tube was incubated for an additional
3 min. After 3 min centrifugation at maximum speed, supernatant
containing cytoplasmic extract was carefully transferred to a clean
pre-chilled tube. Nuclear extraction reagent was then added to the
pellet and the tubewas incubated on ice for 40min. After centrifugation
at maximum speed, the supernatant containing nuclear extract was
transferred to a clean pre-chilled tube.
2.7. Western blotting
Western blot analysis was performed according to standard proce-
dures. Protein concentration was measured using a Bradford assay
(Bio-Rad). The same concentration of proteins (50 μg) from different
fractions was separated on 12% SDS-PAGE and transferred to PVDF
(polyvinyl diﬂuoride) membrane (Sigma-Aldrich). The membrane was
blocked with 5% non-fat milk in PBS containing 0.05% Tween-20 for
45min at room temperature and then incubated with primary antibod-
ies against STAM2 (rabbit polyclonal, diluted 1:1000, Abcam, ab63372),
HDAC2 (mousemonoclonal, diluted 1:500, Abcam, ab12169), and VEGF
(rabbit polyclonal, diluted 1:5000, Abcam, ab46154) at 4 °C overnight.
Immune complexes were revealed using appropriate secondary
antibodies coupled with horseradish peroxidase: goat anti-mouse IgG,
HRP (diluted 1:5000, Abcam, ab6789) and goat anti-rabbit IgG, HRP
(diluted 1:5000, Abcam, ab6721) for 2 h at room temperature, followed
by chemiluminescent detection (Immobilon Western Chemilumines-
cent HRP Substrate; Millipore) and imaged using ChemiDoc XRS+
imaging system analyzed by Image Lab 5.2 software.
2.8. Expression data analysis
The anatomical structures of the mouse brain were identiﬁed with
the aid of a mouse brain atlas (Dong, 2008; Hof et al., 2000). The inten-
sity of an X-gal-staining area, RNA in situ hybridization signal and
STAM2 antibody intensity were evaluated semiquantitatively through
a microscope using the following categories: no signal (−); low signal
(+); moderate signal (++) and high signal (+++). The results were
rated independently by two observers and in case of disagreement a
third observer was engaged.
2.9. Quantiﬁcation of the immunoﬂuorescence signal
For the quantiﬁcation of the STAM2 and NeuN immunoﬂuorescent
signal samples were taken from four animals. Five randomly chosen
sections of the cortex, hippocampus and striatum per animal and
three ﬁelds per section were analyzed on a confocal microscope (Zeiss
LSM 510 Meta). The number of positive cells in a ﬁeld was counted
manually.
3. Results
3.1. Stam2 was highly expressed in the mouse brain including the
neocortex, hippocampus, olfactory bulb and cerebellum
Brain Stam2 expressionwas evaluated by in situ hybridization inwild
type mice, X-gal staining, reﬂecting the activity of the lacZ reporter gene
in Stam2Gt1Gaj mouse line and using STAM2 immunohistochemistry
(Figs. 1–3). Regions of high-level expression were detected by all
three techniques with high reproducibility. However, β-galactosidase
activity resulting from lacZ expression allowed better delineation
of different brain substructures, as previously observed for other
111K. Kapuralin et al. / Molecular and Cellular Neuroscience 67 (2015) 104–115genes (Couegnas et al., 2007), being a convenient, sensitive and high-
resolution assay to detect the overall pattern of endogenous gene
expression (Burn, 2012).
The distribution and relative intensity of the mRNA transcript
of Stam2 gene, relative intensity of X-gal positive areas and STAM2
immunoﬂuorescence in different brain regionswere semiquantitatively
scored (Table 1). All three methods revealed appreciably high levels of
Stam2 in layer II and layer III (lamina granularis externa and lamina
pyramidalis externa) of the neocortex and in the hippocampus, withinthe pyramidal layer of the CA1 and CA2 ﬁelds of Ammon's horn and
in gyrus fasciolaris. Strong Stam2 expression was also found in the
olfactory bulb throughout the glomerular layer of the main olfactory
bulb and in the anterior olfactory nucleus (Čunko et al., 2008). It was
also found in the medial habenula of the epithalamus, and in the
ventromedial and dorsomedial hypothalamic nuclei. In themetenceph-
alon the highest Stam2 expression was found in the cerebellum, mostly
in the granular layer (Figs. 1–3). Additionally, a very weak, ubiquitous
signal was visible in every cell, whichwas in accordancewith a previous
northern blot and RT-PCR analysis (Ćurlin et al., 2012; Takata et al.,
2000).
The accuracy with which the fused lacZ-Stam2 reporter gene
reﬂected the endogenous presence of STAM2 protein was determined
by comparing STAM2 immunohistochemistry and β-galactosidase
presence. Cryosections of heterozygous Stam2+/Gt1Gaj brainwere doubly
labeled with STAM2 and β-galactosidase antibody. Immunohistochem-
istry against both antigens revealed a strong ﬂuorescent signal in the
Stam2-expressing regions identiﬁed by in situ hybridization and X-gal
staining (Figs. 1B, 3). The overlap in the distribution of STAM2 and β-
galactosidase proteins conﬁrmed the observed expression pattern.
This served as an evidence that the gene trap mice in general, and
Stam2Gt1Gaj mice in particular, are appropriate animal models for
expression studies.
Still in somebrain areas (corpusmamillare, hypothalamic nuclei and
hippocampal dentate gyrus) the reporter gene expression showed
lower signal strength as observed by RNA in situ hybridization and
immunohistochemistry (Table 1). Such “mismatches” were expected
due to different detection levels of the three methods used. Both,
mRNA expression and immunohistochemistry showed the weak
ubiquitous signal not visible by X-gal staining. It was shown previously
that lacZ histochemistry might underestimate the extent of gene
expression or protein distribution (Couegnas et al., 2007; Mahony
et al., 2002; Pereira et al., 2006). The lacZ expression could not be
considered as a disadvantage, as it revealed positive areas, correspond-
ing to the high level of Stam2 expression.
In order to verify whether Stam2 expression in the brain changes
with age we performed an immunostaining assay for STAM2 on 4-
month-old and 12-month-old mice. The staining pattern of STAM2
remained the same in both age groups (Fig. 3, Supplementary Table 1).
3.2. Stam2 expressing cells were predominantly neurons
In order to identify cell types expressing Stam2, brain cryosections
were co-immunostained with STAM2 antibody and markers speciﬁc
for neurons and glial cell types. The majority of STAM2-positive cells
were co-labeled for neuronal markers MAP2 (the neuron-speciﬁc
cytoskeletal marker) and NeuN (the neuron-speciﬁc nuclear marker),
indicating that STAM2-positive cells were predominantly neurons
(Fig. 4A). The percentage of cells co-expressing STAM2 and NeuN in
the region of the cortex, hippocampus and striatum was 94.3%, 94.3%
and 88.4% of the total stained cells respectively (Fig. 5). In neurons,
STAM2 was visible in the cytoplasm throughout the soma and nerve ﬁ-
bers, showing a punctuate appearance and high ﬂuorescence intensity.
Rather unexpectedly, STAM2 was also visible in neuronal nuclei, and
the nuclear signalwas homogenously distributed. Glial cells (astrocytes,Fig. 6. Subcellular localization of endogenous STAM2 in primary neurons. (A) After 6 days
in a culture, immunostaining with neuronal marker MAP2 demonstrated that the cells
were predominantly neurons (arrows). (B) Primary neurons cultured for 6 days were
co-stained with STAM2 and EEA1 antibody (arrows), indicating that STAM2 protein was
localized mainly to the early endosome membrane. (C) After 14 days in a culture
double-labeling results clearly showed that the cells in culture were positive for STAM2
and neuronalmarkerMAP2 (arrows). (D) Double stainingwith STAM2 and EEA1 antibody
conﬁrmed that STAM2 was localized in the punctuate structures positive for EEA1 in the
mature neurons as well (arrows). (E) Arrows indicate co-localization of STAM2 with
HRS, suggesting that the ESCRT-0 system is functional in neurons. (F, G) STAM2 partially
co-localized (arrows) with AMSH (F) and UBPY (G), indicating an interaction between
STAM2 and deubiquitinating enzymes in neurons. All bars are 10 μm.
Fig. 7. Nuclear localization of STAM2 in neurons. (A) Primary neuronal cells obtained from the mice cortex were subjected to subcellular fractionation, as described in the Material and
Methods section. Proteins from different cellular fractions (cytoplasmic and nuclear) were analyzed by SDS-PAGE and immunoblotted with STAM2 antibody. STAM2 protein was
found in the cytoplasmic (NP) andnuclear (NU) fractions. VEGF andHDAC2were used to conﬁrm the integrity of each fraction. (B, C, D) Confocalmicroscopy images depicting intracellular
nuclear localization of STAM2 in primary neurons. Neuronal cells were immunostained for endogenous STAM2 using three different antibodies obtained from Abcam (B), Bioworld
Technology (C) and Santa Cruz Biotechnology (D). STAM2 was found to be partially localized in the nuclei (arrows), as well as in the cytoplasm (arrowheads) of neuronal cells. All
bars are 10 μm.
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weaker STAM2 signal than that in neurons. STAM2 exhibited a similar
cytoplasmic staining pattern in both cell bodies and processes, but not
in the nucleus (Fig. 4B, C). O4 antibody as amarker for oligodendrocytes
showed aweak signal for STAM2protein, similar to theweakubiquitous
staining observed in every cell (Fig. 4D).
3.3. In the cytoplasm of the neurons STAM2 was localized on the early
endosomes as a part of the ESCRT-0 complex
Although STAM2 was previously suggested to be involved in
endosomal trafﬁcking, it remained unclear whether it was associated
with the endosomes in the neurons. To examine subcellular localization
of STAM2 protein, adult brain tissue and primary neurons cultured for 6
and 14 dayswere used for immunohistochemical analysis (Fig. 6A, C). In
double-labeling experiments with EEA1 (a protein present in the
early endosome membrane) an extensive but not a total overlap was
observed (Fig. 6B, D).
Since STAM2 is an ESCRT-0 member, we next examined its co-
localization with HRS, the other ESCRT-0 member, and ESCRT-0-
associated deubiquitinating enzymes AMSH and UBPY. STAM2 was
co-localized with HRS both in vitro and in vivo (Fig. 6E), and partially
co-localized with AMSH and UBPY (Fig. 6F, G).
3.4. Stam2 was localized in the neuronal nuclei
In addition to cytoplasmic staining, STAM2 antibody showed a
homogenous strong signal in the neuronal nuclei. This ﬁnding wasnovel and rather unexpected, as STAM2 was considered to be local-
ized only on the cytoplasmic surface of early endosomes (Bache
et al., 2003; Takata et al., 2000). To verify its nuclear localization, im-
munohistochemical analyseswere performedwith three different com-
mercial antibodies obtained from three different companies (Abcam,
Bioworld Technology and Santa Cruz Biotechnology), representing all
commercially available antibodies at the time the experiments were
performed. NeuN, amarker speciﬁc for neuronal nuclei was used to val-
idate the STAM2 nuclear signal (Fig. 5). All three different STAM2 anti-
bodies showed a homogenous signal in neuronal nuclei (Fig. 7B–D).
Another approach to analyze STAM2 intracellular localization was
subcellular fractionation on neuronal cells obtained from the primary
culture. Proteins from different cellular fractions (cytosolic and nuclear)
were analyzed by SDS-PAGE followed by western blotting with a
STAM2 antibody. Western blotting conﬁrmed a considerable amount
of STAM2 in the nuclear fraction as well as in the cytosolic fraction.
VEGF and HDAC2, were detected in the cytoplasmic and nuclear
fractions respectively, to conﬁrm the integrity of each fraction
(Fig. 7A). These results were consistent with the immunocytochemical
staining, indicating that STAM2 was indeed present in the neuronal
nuclei.
3.5. STAM2-associated proteins were not localized in the nucleus
The newly identiﬁed STAM2 neuronal nuclear expression prompted
us to analyze whether STAM2-associated proteins, STAM1, HRS, AMSH
and UBPY, would be in the nucleus as well. Immunohistochemistry
to these proteins in the primary neuronal culture revealed two types
Fig. 8. Immunolocalization of STAM2-associated proteins in the brain. Confocal microscopy was employed to show localization of endogenous STAM1 (A), HRS (B), AMSH (C) and UBPY
(D) at the cortex level. HRS and UBPY (A, D) antibodies were expressed in punctate patches throughout the cytoplasm, whereas the STAM1 and AMSH (B, C) staining was intense partic-
ularly in perinuclear regions of cells without detectable nuclear staining. All bars are 10 μm.
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mic staining was observed for HRS (Fig. 8A) and UBPY (Fig. 8D). In
contrast, STAM1 (Fig. 8B) and AMSH (Fig. 8C) staining was diffuse
throughout the cytoplasm, with a punctuate pattern surrounding the
nuclear membrane. The nuclear localization of these STAM2-associated
proteins was never observed, suggesting that these endosome-related
proteins were not together with STAM2 in the nucleus of neurons.
4. Discussion
Spatial expression of Stam2 in the mouse brain was similar to that
reported for other ESCRT-0 members, Stam1 and Hrs. The regions of
high expression of Stam2 mRNA coincided with the regions of Stam1
and Hrs mRNA-expressing cells in the brain (Tamai et al., 2008;
Yamada et al., 2001). All these genes are highly expressed in the cerebral
cortex, hippocampus and cerebellar cortex,while high Stam1 and Stam2
expression overlapped in the olfactory bulb and caudate putamen
region. When compared with other STAM2-associated proteins, there
was an overlap between the regions of high Stam2 expression and
high Amsh expression in the cerebral cortex, olfactory bulb, hippocam-
pus and cerebellum region (Ishii et al., 2001). All these genes together
with Stam2 were found to be highly expressed in the hippocampus. It
was previously reported that STAM2-interacting proteins contributed
to hippocampal pyramidal cell survival in vivo; loss of STAM1 or HRS
caused signiﬁcant disappearance of neurons in the CA3 region of the
hippocampus and loss of AMSH led to neuronal loss in the CA1 subﬁeld
of the hippocampus (Ishii et al., 2001; Tamai et al., 2008; Yamada et al.,
2001). There is no evidence of the loss of hippocampal neurons after the
loss of STAM2 in themutant micewith the function, but the loss of both
STAMproteins is indeed embryonically lethal, implying that STAM1 and
STAM2 compensate for each other (Yamada et al., 2002). STAM2 cannotcompensate for all the functions mediated by STAM1, as shown by CA3
pyramidal cell loss in STAM1−/−mice. We showed that in the CA3 sub-
ﬁeld the expression level of Stam2 was lower than in the CA1 and CA2
subﬁelds of the hippocampus.
High Stam2 expression was found in neuronal cells in most regions
of the mouse brain, while its expression in astrocytes, microglia and ol-
igodendrocyteswas lowbut detectable. Thiswas in accordancewith the
distribution of STAM2-immunoreactive cells described in the enteric
nervous system, where the majority of STAM2-positive cells co-
stained with neuronal markers, while enteroglial cells showed a weak
STAM2 signal (Kapuralin et al., 2012). A low level of STAM2 signal in
various tissues has been previously described (Ćurlin et al., 2012;
Takata et al., 2000), but here we demonstrated a different expression
within different cell types of the nervous system.
STAM2 subcellular distribution was granular cytoplasmic, co-
localized with early endosome marker EEA1, and members of the
ESCRT-0 complex, STAM1 and HRS. This was related to the vesicular
transport through early endosomes for down-regulation of the growth
factor/receptor complexes (Bache et al., 2003; Takata et al., 2000).
STAM2 was localized at axons and dendrites, indicating its possible
role in endosomal trafﬁcking at presynaptic and postsynaptic sites.
Endosomes regulate a large number of processes in neurons, including
formation and recycling of synaptic vesicles, retrograde axonal trans-
port, growth factor-mediated cell signaling, degradation of proteins, ax-
onal pathﬁnding during development, synaptic plasticity and more
(Nixon and Cataldo, 1995; Schmieg et al., 2014; Steketee and
Goldberg, 2012). Neurons are particularly sensitive to defects in the
endosomal–lysosomal system, and its disruption is linked to several
neurodegenerative diseases. Mutations in various proteins of the
ESCRT complex are responsible for accumulation of ubiquitin-positive
protein inclusions in the central nervous system, leading to
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Gao, 2012; Rusten and Simonsen, 2008; Saksena and Emr, 2009;
Stuffers et al., 2009). The presence of STAM2 in neurons contributed
to the evidence that ESCRT proteins play an important role in the brain.
The novel ﬁnding of nuclear localization of STAM2 in the neurons
was conﬁrmed by different approaches (immunolocalization and
western blot on puriﬁed subcellular fractions). STAM2 lacks a nuclear
localization sequence, and the previous studies showed endosomal
and cytoplasmic STAM2 localization only (Bache et al., 2003; Takata
et al., 2000). STAM2 in vitro studies were performed on non-neuronal
cells only (Endo et al., 2000; Kanazawa et al., 2003; Mizuno et al.,
2003; Rismanchi et al., 2009; Takata et al., 2000), and the data presented
here pointed to the importance of further investigations of this protein
in neuronal cells. The lack of nuclear co-localization of STAM2 with
other ESCRT-0 and ESCRT-0-associated proteins, AMSH and UBPY, sug-
gested that it had an additional function in neuronal nuclei independent
of the ESCRT pathway. STAM2 is also involved in the regulation of
intracellular signal transduction for DNA synthesis and induction of
proto-oncogene c-MYC (Komada and Kitamura, 2005; Takeshita et al.,
1997) being at the intersection of signaling pathways and membrane
transport in the cell, which might well contribute to its nuclear
expression.
Similarly to STAM2, TSG101, CHMP1, and CHMP3 are the ESCRT
proteins also present in the nucleus (Tu et al., 2011). They share some
features of the so-called “two-faced” proteins that have a dual role
and regulate signaling pathways in seemingly opposite ways under
different physiological conditions. TSG101, a member of the ESCRT-I
complex binds the glucocorticoid receptor and inhibits transcriptional
activation. CHMP1, a member of the ESCRT-II complex plays a role in
chromatin remodeling, while CHMP3, a key component of ESCRT-III, is
localized to the nucleus in addition to endosomes (Hittelman et al.,
1999; Stauffer et al., 2001; Whitley et al., 2003). All these ﬁndings
together suggest that some ESCRT proteins might serve as a link be-
tween endosomal sorting and transcriptional regulation.5. Conclusion
Our study described for the ﬁrst time the regional distribution of
Stam2 expression in the mouse brain and in the neurons. STAM2 was
localized both in the cytoplasmic and nuclear compartment of the
neurons. The newly identiﬁed neuron-speciﬁc nuclear localization of
STAM2, together with its high expression in the brain indicated that
STAM2 might have a speciﬁc function in the mouse nervous system.
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